ArticleProceedings of the National Academy of Sciences of the United States of America2018

Phosphodiesterase 2 inhibition preferentially promotes NO/guanylyl cyclase/cGMP signaling to reverse the development of heart failure.

Reshma S Baliga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.